Eximore vs NewStem
Eximore vs NewStem, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Eximore is on 52/100 and NewStem on 45/100.
Where each one leads
Eximore
- our overall score: 52/100 against 45/100
- domain rating: 7/100 against 4/100
NewStem
- funding raised: $30.0M against $10.0M
At a glance
| Measure | Eximore | NewStem |
|---|---|---|
| What it is | Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies. | Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy. |
| Category | Life Sciences, Biopharmaceutical, Biotech, MedTech | Life Sciences, Biotech, Biopharmaceutical, MedTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2014 | 2018 |
| Headquarters | Tel Aviv, Israel | Rehovot, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Eximore | NewStem |
|---|---|---|
| Employees | 7 | Not published |
| Total funding | $10.0M | $30.0M |
| Latest round | Series A | Series B |
| LinkedIn followers | 89 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Eximore | NewStem |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 52/100 | 45/100 |
| Traction | 44/100 | 37/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 29/100 | 9/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 7/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Eximore | NewStem |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
Eximore vs NewStem: common questions
Which is better, Eximore or NewStem?
On our 0-100 score Eximore rates higher (52/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Eximore and NewStem compare on the numbers?
Eximore leads on our overall score (52/100 against 45/100), domain rating (7/100 against 4/100). NewStem leads on funding raised ($30.0M against $10.0M).
Read the full Eximore review and pricing or the NewStem review and pricing. You can also browse other Eximore alternatives we track.